Dyslipidemia Prevalence among Tinnitus Patients of a Referral ENT Clinic in Tehran, Iran, 2018
International Clinical Neuroscience Journal,
Vol. 6 No. 2 (2019),
29 June 2019
Background: Tinnitus is a common neurosensory disorder that can bring many problems such as stress and sleep disorders to the patients and affect their quality of life. Unfortunately, its pathophysiology has not been exactly discovered yet, but there have been some studies executed about the possibility of dyslipidemia causing tinnitus. Studying more on this subject and especially on the Iranian population in order to provide us with evidence-based information, can help us find the optimal method to control and treat this disorder.
Methods: In this study, 76 patients that have had complaints of tinnitus in the ENT (ears, nose, and throat) clinic of Taleghani hospital, Shahid Beheshti University of Medical Sciences, in the year 2018, were selected. Also, after taking a history about the severity and the onset of their problem, they were examined and also blood samples were taken to check their lipid profiles. Finally, the results of the lab tests, the severity and the onset of their disorder and also their age and sex were statistically analyzed.
Results: The study showed that the prevalence of dyslipidemia in patients with tinnitus is not significantly greater than its prevalence in the general population. Furthermore despite the relationship between dyslipidemia and the onset and severity of the tinnitus is not significant, the effect of dyslipidemia on tinnitus shows itself after about one year and a half (P=0.000), it means dyslipidemia does not cause the tinnitus but affects in its duration. It also indicated the most common type of dyslipidemia among the patients that we studied, was Hypercholesterolemia with the prevalence of 23.68%.
Conclusion: The Study suggests that despite the Hypercholesterolemia prevalence of 23.68% among these patients, dyslipidemia does not have a significant relationship with the severity of the neuro-sensory disorder “tinnitus’ overall, but dyslipidemia affects tinnitus after suffering for about one year and a half. Therefore there will not be a need to use blood tests in order to measure the lipid profile factors at the beginning and the first months of the patients’ tinnitus.
How to Cite
Baguley D, McFerran D, Hall D. Tinnitus. Lancet. 2013;382(9904):1600-7. doi: 10.1016/s0140- 6736(13)60142-7.
Huang YS, Koo M, Chen JC, Hwang JH. The association between tinnitus and the risk of ischemic cerebrovascular disease in young and middle-aged patients: A secondary case-control analysis of a nationwide, population-based health claims database. PLoS One. 2017;12(11):e0187474. doi: 10.1371/journal.pone.0187474.
Jastreboff PJ, Jastreboff MM. Tinnitus retraining therapy: a different view on tinnitus. ORL J Otorhinolaryngol Relat Spec. 2006;68(1):23-9; discussion 9-30. doi: 10.1159/000090487.
Norena AJ, Farley BJ. Tinnitus-related neural activity: theories of generation, propagation, and centralization. Hear Res. 2013;295:161-71. doi: 10.1016/j.heares.2012.09.010.
de Moraes Marchiori LL, de Almeida Rego Filho E, Matsuo T. Hypertension as a factor associated with hearing loss. Braz J Otorhinolaryngol. 2006;72(4):533-40.
Perez R, Ziv E, Freeman S, Sichel JY, Sohmer H. Vestibular end-organ impairment in an animal model of type 2 diabetes mellitus. Laryngoscope. 2001;111(1):110-3. doi: 10.1097/00005537-200101000-00019.
Tachibana M, Yamamichi I, Nakae S, Hirasugi Y, Machino M, Mizukoshi O. The site of involvement of hypertension within the cochlea. A comparative study of normotensive and spontaneously hypertensive rats. Acta Otolaryngol. 1984;97(3-4):257-65.
Holcat M. [Tinnitus and diabetes]. Vnitr Lek. 2007;53(5):534- 6.
Wang H, Tian J, Yin D, Jiang S, Yang W, Han D, et al. Regional glucose metabolic increases in left auditory cortex in tinnitus patients: a preliminary study with positron emission tomography. Chin Med J (Engl). 2001;114(8):848-51.
Spencer JT Jr. Hyperlipoproteinemia and inner ear disease. W V Med J. 1974;70(9):215-21.
Kazmierczak H, Doroszewska G. Metabolic disorders in vertigo, tinnitus, and hearing loss. Int Tinnitus J. 2001;7(1):54- 8.
Cooper JC Jr. Health and Nutrition Examination Survey of 1971-75: Part II. Tinnitus, subjective hearing loss, and well-being. J Am Acad Audiol. 1994;5(1):37-43.
Anbari S, Isazadeh D, Safavi A, Alaie M, Azizi F. The role of dyslipidemia in sensorineural hearing loss in children. Int J Pediatr Otorhinolaryngol. 2010;74(1):32-6. doi: 10.1016/j. ijporl.2009.10.003.
M-Shirazi M, Farhadi M, Jalessi M, Kamrava SK, Heshmatzadeh- Behzadi A, Arami B. Prevalence of dyslipidemia among Iranian patients with idiopathic tinnitus. J Res Med Sci. 2011;16(7):890-6.
Basut O, Ozdilek T, Coskun H, Erisen L, Tezel I, Onart S, et al. [The incidence of hyperinsulinemia in patients with tinnitus and the effect of a diabetic diet on tinnitus]. Kulak Burun Bogaz Ihtis Derg. 2003;10(5):183-7.
Arnold M, Bousser MG, Fahrni G, Fischer U, Georgiadis D, Gandjour J, et al. Vertebral artery dissection: presenting findings and predictors of outcome. Stroke. 2006;37(10):2499- 503. doi: 10.1161/01.str.0000240493.88473.39.
Qian LQ, Wang B, Niu JY, Gao S, Zhao DY. Assessment of the clinical effect of Chinese medicine therapy combined with psychological intervention for treatment of patients of peri-menopausal syndrome complicated with hyperlipidemia. Chin J Integr Med. 2010;16(2):124-30. doi: 10.1007/s11655- 010-0124-x.
Pulec JL, Pulec MB, Mendoza I. Progressive sensorineural hearing loss, subjective tinnitus and vertigo caused by elevated blood lipids. Ear Nose Throat J. 1997;76(10):716-20, 25-6, 28 passim.
Evans MB, Tonini R, Shope CD, Oghalai JS, Jerger JF, Insull W Jr, et al. Dyslipidemia and auditory function. Otol Neurotol. 2006;27(5):609-14. doi: 10.1097/01. mao.0000226286.19295.3
- Abstract Viewed: 215 times
- PDF Downloaded: 270 times